2021-03-31-accounts - Croydon Health Services Charitable Fund And Other Related Charities

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

ANNUAL		RE	P	OR	T 2	020/2	02	t
Who we are
Our mission
How does Croydon Health		Services	charitable		fund operate
Our charitable impact
Objectives for 2021/22
Get involved
Structure, governance	and	management
Croydon Health Services charitable			fund corporate trustee
Our corporate trustees
Review ofthe finances,	achievements			lit performance		ofthe charitable	fund	11
Policies								14
Risk management								15
Key management personnel		remuneration						15

Name		Designation				From *	To
Matthew	Kershaw	Joint chief executive and place based leader			for health	01-Oct-18	Present
Mike Sexton		Joint chief finance	officer			01-Nov-19	Present
Nnenna	Osuji	Medical director				O'I-Sep-1S	30Jun-21
Elaine Clancy		Chief nurse				01-May-19	Present
Michael	Burden	Director of human	resources	&organisational	development	01-May-13	Present

Non-executive	directors (with voting rights)	directors (with voting rights)
Name	Designation		From *	To
Michael Bell	Chairman		02-Jan-13	Present
Steven Corbishley	Non-executive	director	01-Apr-13	Present
Godfrey Allen	Non-executive	director	14-Jan-13	Present
Dr James Gillgrass	Non-executive	director	01-Jan-14	30-Jun-20
Louise Cretton	Non-executive	director	01-Jan-14	Present
Mike Bailey	Non-executive	director	01-May-14	Present
Hannah Miller	Non-executive	director	01-Oct-15	31-Dec-20
Richard Oirschot	Non-executive	director	Ot-Sep-17	31-Aug-20
Jamal Butt	Non-executive	director	01-Feb-20*	Present
Philip Hogan	Non-executive	director	01-Apr-20	Present
Paulette Lewis	Non-executive	director	01-Apr-20	Present
Dawn Reid	Non-executive	director	01-Mar-20	Present

REVIEW OF THE FINANCES, ACHIEVEMENTS AND PERFORMANCE OF THE CHARITABLE FUND

croydonhealthservices Qcroydonhealth in Croydon Health SeThi NHS Tw5t Croydonhealth." QcToydonhealthser¥ice5 www.(roydonhealthserviceknhs.uk

		(D N Al	m 0	N 0 L	(D (0 (D		GI (O (0 (D	GI (O (0 (D	(fl GI								Cl (D							CD PI	N If) N
		CI		IL
			'O 0 0	N '0 L	Cl CD (0		(D (D D N						G(	CI	(0 Cl	(Q	(D	(5 N							N CO
				IL
			N0
			EL'
			'080	N 0 L	(3 (D (D														CI CI			CI IA
			N0
		N O	(50	Ol '0 0	Cl O (D ttt								(3	I	N (0	OD	CTI (D			CI IA	(D	(D (0		N (A N	(A IA OO
		CI N		U
			'0 0 v 0	IO (0 55 (0 C(D																CI IA	CD	CI IA
				U
			tO0
			00	(O '0	(0 (0 (D								(D	N	N	I	IA			(O CI	(O	CI
CI N CI	CI N		N Cl	U
IO	0I		CD
000 (5	(5 K (O'0 (D						N		G(																	(5 C
CL C U. Cl IO t(5 O N Cl0 2 fh m Clx L0'0 0 O	C0I ttl Cl 0 I0 N0 (50L GIL IL 0 00 E0 (A					00 Gl CD0 'l3 Gl E C CI 0 I (5 0 L EB 0C		IO Cl0 N .0 o (O Z (O Cl L C mE~ Cl 0 N O m m 0 m0I-		0 Cl C 00( If IU	Gl'0 IL C (O IO	(O & 0 0 m C CJ	C ID EcL 0 UJ 0 Z 0 vl O 0 CL	0 E (5 0 COl IO	0 m0 LLI 05 0 Gl0 N m CL (50 Cl	(6 ID C Cl Cl E'C (O (5 cl 0 E— Gl mm0 ID Cl JD N ID 0 5— (5 5! (5 0 (0 0		Cl 15 ClIL X IU (50 I	N 0 E (O ID C0 N0 thN0 (OC m0 0Z	0 Cl I( Cl COL E C ClZ	th C c tD Cl 0 VlC	(O 15 IL C C Cl E Cl 0 ClZ	N'0 c o m 0 CI 0 K	ClN (D N 0 m t5 'p m Ol 0 JD N 0 0C (5 JD L	N CI CC J0 I(5 K (5 (5'0 IO '0 Cl I(50 N Cl0 (5 (5 '0 C IL	000 (5 Cl IO Cl 0 mO. E (D 0 CO (O ID Ol mO. (5 IO ID0 Cl

	Ct	(0 Vt	V U	O O NO OO N 4l	O O NO OO N 4l			Gt O ID	(0	O								N CD	O	LD N
	Cl																					IU
	Vl CtK	LL (00																				(D V
																						IDX
		'0S V	Vt '0 C LL		O o O4!													EU tX)	O			LLJ Q O
		Ut
		ID
																						Cl
		0 ID V	N '0 C		O o O4!			QO	N N	0! U)								O	O			U!S
		UtQ																				(0
		tll C	V Cl	«O No CI O		ID ID	CO ID												ID	ID ID OO		(0 Qt N
		LL																				C0
		m0I-																				QtCat
																						U!
		'a CI V IO Cl		N '0 C 0 I4	O o O 4l															T Ut		IU CtN
		IL
																						Cl
		'0 Q V I (O		NO '0o CO 0 4I (4																		C tU (0 N00
N Ct		CI																				(U (DQ
N CI																						N
N		IC
Vl 0V		Ct0Z																O	O			Q a
~C	T(« Cl														(0S						IU	Qt 0
C ~L' I'0 C LL Clr IO m O IC CIV QN IO CIZ C0'0 0 O	V« V mZ Cl Vl III 0 IC00. m V IOC I4 «0 C Ct E ( m N				N cl ilt N Q 0	Ut C (6 Q	IO Q Ul N '0 Cl 0 I	Vt N0 GL 0t '0 C(0 CSE NQ E 0 0 IDc O N	C (0 Ea C(0 m IUr N0 (0	N QN «L' C 44 IO0I-	IO Q .'= Zl m	(0 (0 QlC0 C IDa 00 C Ql Ut C 0 Vt 'am Qt O	IC Ct Z! Cl 8 Cl IC «t C I ~ Q z IO0	Vt Cl m C I ~ 0 0z	0! 0 Qt0E 0t m ID 0! (0 Ut C P E (6 00 tD 0	Q m ~ 0 N Cl 0! N IO « Ct Z IO0	(0 QI Q 0 N Cl I-	N '0C 'a S -" NS CL'	ac (D V N ID C D	IO C LL IO r CJ m0I-	0VV (0S NS 0 IU E (0 0 (0 Ut at IU (U Qt C (D	CL CL (0 Ql Qt (0 0 LD NSat m p N 0tE Ct (0 N m V (0C Lc Qt	IU S s (0S U"0 U! m S V(0	(0 0t S0 (0 Qt 'T3 Cl Vt IU (JJ QV(0 NO C N IU Sz m IU IDD m ID 3 X (0 S DJ ID ID mr (0 ZOCI

					Unrestricted	Restricted	2020/21	2019/20
2.1	Donations 8 Legacies				Funds	Funds	Total	Total
					FOOO	6000	6000	5000
	Donations
	Donations from	Individuals			11	61	72	35
	Corporate Donations				144	636	780	132
	Total Donations				155	697	852	167
	Legacies
	Staff Amenities/	Medical	Equipment		0	50	50	5
	General Purposes Fund				89	0	89	11
	Total Legacies				89	50	139	16
	Total Donations	and Legacies			244	747	991	183
	/n 2020/21 the Trust received			2 legacies	of8139kas compared	to 2019/20 of4 legacies (F16k).
2.2	Charitable Activities
	Grant					30	30	117
	Staff Gym Club					3	3	33
	Study/Course Fees					30	30	*5
	Other Income					0	0	4
	Total Charitable	Activities				63	63	209
2.3	Investment income
					Unrestricted	Restricted	2020/21	2019/20
					Funds	Funds	Total	Total
					6000	f000	FOOO	FOOO
	Bank Interest				0	0	0	1
	Dividends				26	0	26	38
	Total Investment Income				26		26	39
	Total All Incoming Resources				270	810	1,080	431
2.4	Deferred Income:
								Restated
					Unrestricted	Restricted	2020/21	2019/20
					Funds	Funds	Total	Total
					6000	8000	8000	6000
	Balance at 1 April				0	0	0	0
	Released during	the year			0	0	0	0
	Deferred during	the year			0	0	0	0
	Balance at 31 March

Analysis	ofexpenditure	on Raising F	unds
				Support		Support	2020/21	2019/20
				Costs		Costs	Total	Total
			Unrestricted	Unrestricted	Restricted	Restricted
			6000	6000	6000	6000	6000	FOOO
Fundraising Events			0	0	3	0	3	70
Investment Management			13	3	0	0	16	12
Total			13	3	3	0	19	82
Analysis	ofexpenditure	on Charitable	Activities
				Support		Support	2020/21	2019/20
				Costs		Costs	Total	Total
			Unrestricted	Unrestricted	Restricted	Restricted	OOOO	5000
			6000	6000	6000	6000
Purchase	of New Equipment		62	14	54	0	130	110
Building	& Refurbishment		59	13	75	0	147	0
Medical	Research 8 Education		2	0	62	0	64	111
Patients	welfare and amenities		14	3	1	0	18
Staff welfare and amenities			143	32	114	0	289	35
			280	62	306	0	648	260

Analysis ofGrants
	2020/21	2019/20
	Total	Total
Grants to Institutions	6000	f000
Purchase of New Equipment	73	61
Building 8 Refurbishment	133	2
Medical Research & Education	23	77
Staff 8 Patient Amenity	263	101
Total	492	241

Allocation ofSupport	Costs &Overheads
					2020/21	2019/20
		Unrestricted	Restricted		Total	Total
Raising Funds:		6000	6000		6000	5000
Governance - Internal	& External Audit				1	1
Salaries - Finance Administration					2	9
Total Support Costs		3		0	3	10
Charitable Activities:
Governance - Internal	8 External Audit	31			31
Finance Costs - Bank	charges	1			1	1
Salaries - Finance Administration		30			30	28
Total Support Costs		62		0	62	33

Note	4	Analysis ofStaff	Costs
								2020/21	2019/20
								Total	Total
								8000	FOOO
		Salaries and wages						28	27
		Social security costs						3	2
		Employers pension	contribution					0	0
		Total Staff Costs						31	29
		Average monthly VVTE ofemployees		in the	year:			0.85	0.85
		There were no employees with a salary ofover 860k (nil in 2020/21)
Note	5	Reconciliation of Net Income to net		cash flow from operating			activities
								2020/21	2019/20
								Total	Total
								8000	FOOO
		Nei income for the	reporting period (as per		the Statement	of
		Financial Activities)						604	(55)
		Adjustments for:
		Dividends, interest	and rents from investments					(26)	(39)
		Net (Gains)/I oases	on investments					(191)	144
		(Increase)/decrease	in stocks					0	0
		(Increase)/decrease	in debtors					38	74
		Increase/(decrease)	in creditors					49	33
		Adjustment due to	rounding					1	0
		Net cash provided	by (used in) operating		activities			475	157
	5.1	Analysis ofCash at Bank & In hand
								2020/21	2019/20
								Total	Total
								8000	FOOO
		Cash in hand						535	61
		Total cash and cash equivalents						535	61

e 6	Analysis ofMovement of	Invest	ments
				2020-21	2019-20
6.1	Movement in Fixed Asset	Investments:		f000	f000
	Market value at beginning	ofyear	1 April	1,141	997
	Less: Disposals at carrying	value		(525)	(130)
	Add: Acquisitions at cost			552	417
	Net gain/(loss) on revaluation			191	(143)
	Market value at end ofyear 31 March			1,359	1,141

6.2 Market value at 31March:	6.2 Market value at 31March:		2020-21	2019-20
			f000	f000
Investments listed on Stock Exchange			1„359	1,141
			1,359	1,141
Fixed Asset Investment	by type:		2020-21	2019-20
			f000	f000
Fixed Interest			138	191
UK Equity Funds			340	466
Overseas Equity Funds and alternative		Assets	422	334
Property Funds			69	70
Total Listed Investments			969	1,061
Cash on interest Bearing	Deposit		390	80
Total			1,359	1,141
Note 7 Analysis ofCurrent Debtors				Restated
Amounts falling due within one year and over one year:			2020-21	2019-20
			f000	f000
Trade debtors Prepayments			5 5	36*
Total debtors falling due within one year			10

Analysis ofShort Term investments
	2020-21	2019-20
	f000	f000
Short term investments and deposits	11	50
Total short term investments and deposits		50

Health Services Charitable Fund - Annual Accounts	2020/21
Analysis of Liabilities		Restated
	31 Nlarch	31 March
	2021	2020
Creditors under 1 year	f000	f000
Trade creditors	26	0
Amounts due to associated Other Accruals	6 27	0 9 *
Total creditors falling due within one year	59

			Fund						Fund	Fund
2020/21			Balance at 31 March	Income	Expenditure	Transfers	Gains and (Losses)		Balance at 31 March
			2020						2021
			f000	f000	f000	f000	f.000			f000
Material		funds
Medical	& Other Equipment 86			0	(1)						85
Research		&Education 251		46	(59)					239
Staff & Patients Amenities. 329				388	(248)					469
Croydon		CCG	20	1	(0)						21
Premises		& Building	100	375	(1)					474
Restricted		Reserves	26	0	(0)						26
Total			812	810	(309)	0		0		1,313
*Restricted funds are those where the donor has specified that the funds are used only for							a specific	purpose.
			Fund						Fund
2019/20			Balance at 31 March	Income	Expenditure	Transfers	Gains and (Losses)		Balance at 31 March
			2019						2020
			9000	f000	f000	f000	f000			f000
Material		funds
Medical	&Other Equipment 77			21	(11)	(1)		0			86
Research		8 Education 230		118	(97)	0		0			251
Staff &Patients Amenities. 316				133	(118)	(2)		0			329
Croydon		CCG	24	1	(5)	0		0			20
Premises		& Building 0		100	0	0		0			100
Restricted Reserves 70				0	0	0	(44)				26
Total			717	373	(231)	(3)	(44)				812
Unrestricted Funds
			Fund						Fund
2020/21			Balance at 31 March	Income	Expenditure	Transfers	Gains and (Losses)		Balance at 31 March
			2020						2021
			f000	f000	f000	f000	f000			f000
General		Purposes	Fund 366	270	(358)	0		0			278
Unrestricted Reserves 74				0	0	0	191				265
			440	270	(358)	0	191				543

The following funds	The following funds	had i	ndividual va	lues in excess	off50,000at 31 M	arch 2021:	arch 2021:
Name offund			Balance	Fund Origin	Description ofthe	nature and purpose ofeach
			f000		fund
Friends of Croydon			262	Legacies and	To support patient	experience	of Croydon
				donations	University Hospital.
Covid 19				Donations	General amenities	to support staff well being.
Peadiatric	Integrated	Unit	475	Donations	Specific fund for refurbishment		ofthe Peadiatric
PIU					Unit.
Staff Gym			86	Mainly staff	The fund's income	comes from monthly gym
				subscriptions	subscriptions.